Skip to main content

Citi Pharma | Financial Results

Citi Pharma Ltd. (CPHL) Quarterly Report - Q2 Dec 2024

CPHL reported a profit of Rs. 1.1 per share for the quarter ending December 2024. The company did not declare any cash dividend for this period.

For the last four quarters, the cumulative net income amounted to Rs. 3.6 per share, while total cash distribution was Rs. 3.3 per share.

The latest quarter's earnings per share (EPS) showed a 9.3% increase over the average of the previous four quarters. However, the cumulative net income for the last four quarters was 13% lower compared to the prior four-quarter period. Notably, CPHL has not reported a loss in any of the last five quarters.

Revenue in the latest quarter increased by 10% compared to the average of the previous four quarters. Gross profit for the quarter rose by 26% over the average of the last four quarters. Net income saw a 9% increase compared to the average of the previous four quarters. The gross profit margin stood at 15.3%, improving from the 13.3% average of the previous four quarters. The tax rate for the quarter was 34.8%, lower than the 40.9% average over the past four quarters.

As of the week ending 28 February 2025, CPHL outperformed the KSE100 index by 90% over the past three months. Over the past year, CPHL outperformed the KSE100 index by 217%.

Indices Weighting:

CPHL has no exposure in the KSE100, KSE30, or KMI30 indices.

https://dps.psx.com.pk/download/document/248907.pdf



Popular posts from this blog

Brent Crude Logs Biggest Weekly Drop Since September on Weak Demand, Easing Tensions

Oil prices were under pressure this week. Brent crude oil futures fell 1.9% to $73 per barrel on Friday, registering the biggest weekly loss since early September, with prices dropping over 7%. The decline was attributed to weaker demand forecasts from OPEC and the International Energy Agency (IEA), slowing economic growth in China, and signs of easing geopolitical tensions in the Middle East. Both OPEC and the IEA revised down their demand forecasts for 2024 and 2025. China's refinery output declined for the sixth consecutive month, impacted by weak fuel demand and the growing adoption of electric vehicles (EVs). Meanwhile, U.S. crude oil production reached a new record last week. Although a drawdown in U.S. crude inventories and stronger-than-expected retail sales in September provided some support to oil prices, easing concerns about a broader conflict in the Middle East exerted additional downward pressure on the market.
 A Snapshot of Exchange Traded Funds at PSX

PSX Strongly Rebounds

The Pakistan Stock Exchange (PSX) reacted positively to the conclusion of the IMF staff-level agreement and has now recovered a substantial part of the losses sustained on Monday. Today, out of the 1,139-point gain in the KSE-100 Index, around 800 points were contributed by UBL, OGDC, PPL, and Meezan Bank.